TORONTO, ON / ACCESSWIRE / April 29, 2020 / Galway Metals Inc. (TSXV:GWM)(OTC PINK:GAYMF)  (the "Company" or "Galway") is pleased to report significant new drill results from 2 holes at its George Murphy Zone (GMZ) at the Clarence Stream Gold Project in SW New Brunswick. An additional ~5,000m of drilling in the GMZ and Richard Zones have assays pending.

6.5 g/t Au over 14.05m, 9.7 g/t Au over 2.0m, 1.2 g/t Au over 11.0m, 4.9 g/t Au over 2.35m, and 1.3 g/t Au over 3.95m in hole 88 at the GMZ – extending the zone by 230m to the west (Figure 1, Figure 2, Figure 3, Figure 4)
The intersection of 6.5 g/t Au over 14.05m is a 192m stepout below and to the west (137m vertically) from the deepest previous intersection in the vein
11.4 g/t Au over 2.0m, and 1.1 g/t Au over 3.8m in hole 58 at the GMZ – represents new discoveries of 2 new veins at the GMZ, located 75 metres and 150 metres north of the northern-most structure of the GMZ (Figure 2)

"Galway is rapidly expanding the George Murphy Zone in both vertical and horizontal dimensions. The new discovery to the north contains strong quartz veining, which typically carries the gold. The new drilling to the west has shrunk what was an 800m gap between the Richard and GMZ which Galway believes are part of the same system. The 6.5 g/t over 14m is the deepest intersection to date at 335m in any of the 3 zones along this trend – the Jubilee, Richard and George Murphy Zones, which cover 2.5 km of strike length. These 3 zones are not included in the existing Clarence Stream resource, as two of them, the GMZ and Richard, were discovered by Galway after the last resource estimate was released in September 2017. These results, and those that precede them, demonstrate that Clarence Stream is an emerging new gold district in North America," cites Robert Hinchcliffe, President and CEO of Galway Metals.

Assay Highlights

CL20-88: 6.5 grams per tonne (g/t) Au over 14.05 metres (m), including 66.7 g/t Au over 0.9m, and 18.8 g/t Au over 0.5m, plus 9.7 g/t Au over 2.0m, including 24.0 g/t Au over 0.5m, plus 1.2 g/t Au over 11.0m, including 5.6 g/t Au over 0.5m, 4.1 g/t Au over 0.5m, 2.7 g/t Au over 0.5m and 2.6 g/t Au over 0.5m, plus 4.9 g/t Au over 2.35m, including 15.8 g/t Au over 0.65m, plus 1.3 g/t Au over 3.95m, including 4.8 g/t Au over 0.5m, plus 3.4 g/t Au over 0.85m at vertical depths of 321m, 143m, 239m, 335m, 256m, and 262m below surface, respectively; and
CL20-58: 11.4 g/t Au over 2.0m, including 43.5 g/t Au over 0.5m, plus 1.1 g/t Au over 3.8m, plus 1.3 g/t Au over 18.75m, including 8.2 g/t Au over 1.0m, plus 1.6 g/t Au over 7.25m, including 7.5 g/t Au over 0.5m, and 6.7 g/t Au over 0.5m at vertical depths of 137m, 202m, 6.5m, and 26.3m below surface, respectively

The three areas of visible gold in hole GWM20BL-88, located up to 230 metres west of the previous known limit of the GMZ, returned individual assays of 14.0 g/t Au over 0.5m plus 24.0 g/t Au over 0.5m in the first zone, 2.7 g/t Au plus 2.6 g/t Au plus 5.6 g/t Au – over 0.5m each in the second zone, and 66.7 g/t Au over 0.9m plus 18.8 g/t Au over 0.5m in the deepest zone. In total, hole 88 intersected 6 mineralized structures. (Figure 2, Figure 3 and Figure 4).

Two new structures have also been discovered 75 metres and 150 metres north of the George Murphy Zone. Hole GWM20CL-58 intersected 15-30% remobilized quartz veining with 1% arsenopyrite and 5% pyrite in one of the new discoveries, and 10-15% quartz veining with 1% arsenopyrite in the other. Several more zones with strong quartz returned weak assays. (Figure 2).

Hole 58 targeted the previously northern-most structure in the GMZ to intersect it at surface, 75 metres above recently released hole 37 that returned 6.3 g/t Au over 30.0m, including 20.3 g/t Au over 6.0m, and 43.3 g/t Au over 1.0m. Drilling was undertaken in order to see if this structure, which had only been intersected at depth, could also be intersected towards surface where it might more likely be included in a pit-constrained resource estimate. The intersection in this zone returned 1.6 g/t Au over 7.25m, including 7.5 g/t Au over 0.5m, and 6.7 g/t Au over 0.5m (which had V.G.). Hole 58 intersected another structure that returned 1.3 g/t Au over 18.75m, including 8.2 g/t Au over 1.0m. As such, hole 58 intersected 4 mineralized structures that returned the assays reported and several more structures that had strong veining but only anomalous assays.

Galway's George Murphy Zone discovery was initially reported in December 2017, but drilling stopped a year later in mid-November 2018, following the discovery of the Richard Zone, which was first reported in January 2019. Drilling at the GMZ resumed a year later in mid-November 2019. The plunge of all zones to date in the Jubilee, Richard, and GMZ are thought to be to the west (further suggesting that all 3 are part of the same 2.5 km long system).

The GMZ is now 730m long, with multiple structures over 310m horizontal thickness, and with all zones open in every direction. The gap between the GMZ and Richard Zones is now 650 metres, down from 1.0km originally. Galway plans to drill this gap when it's safe for the resumption of drilling following the current COVID-19 pandemic.

Table 1. Assay Results

Hole ID

From
(m)

To
(m)

Intercept
(m)

Au
g/t

GWM20CL-88

70.35

70.85

0.5

1.1

201.5

203.5

2.0

9.7

incl.

201.5

202.0

0.5

14.0 VG

incl.

203.0

203.5

0.5

24.0 VG

210.9

211.5

0.6

0.4

214.15

214.85

0.7

0.4

225.5

226.0

0.5

0.6

268.2

269.0

0.8

0.4

302.1

303.1

1.0

1.8

307.6

308.4

0.8

0.9

324.0

324.85

0.85

0.4

335.0

346.0

11.0

1.2

incl.

335.0

335.5

0.5

4.1

incl.

341.4

341.9

0.5

2.7 VG

incl.

341.9

342.4

0.5

5.6 VG

incl.

342.4

342.9

0.5

2.6 VG

365.05

365.55

0.5

0.9

366.5

367.0

0.5

0.4

368.75

372.7

3.95

1.3

incl.

371.5

372.0

0.5

4.8

378.65

379.5

0.85

3.4

416.65

417.35

0.7

2.4

432.4

433.15

0.75

1.3

462.0

476.05

14.05

6.5

incl.

471.2

471.7

0.5

18.8 VG

incl.

472.7

473.6

0.9

66.7 VG

490.65

493.0

2.35

4.9

incl.

492.35

493.0

0.65

15.8

GWM20CL-58

9.0

27.75

18.75

1.3

incl.

17.0

18.0

1.0

8.2 VG

36.75

44.0

7.25

1.6

incl.

43.0

43.5

0.5

7.5

incl.

43.5

44.0

0.5

6.7 VG

191.0

193.0

2.0

11.4

incl.

192.0

192.5

0.5

43.5 VG

287.6

291.4

3.8

1.1

VG = visible gold. 0.42 g/t Au was used for the bottom cut-off; True widths are unknown if not noted; all VG samples are done with metallic screen assays (except the 43.5 g/t Au in hole 58, which is gravimetric)

New Brunswick Junior Mining Assistance Program

Galway would like to acknowledge financial support from the New Brunswick Junior Mining Assistance Program, which partially funded drilling of the GMZ, Jubilee, and Richard Zones.

Geology and Mineralization

The recent discovery of the Richard Zone in hole 12 contains elevated levels of bismuth, arsenopyrite, and antimony, in multiple quartz veins, with tungsten in the vicinity. This is similar to other Clarence Stream deposits, which can be characterized as intrusion-related quartz-vein hosted gold deposits. Richard Zone contains multiple zones of quartz veining with sulfides and sericite alteration. In general, mineralization at Clarence Stream consists of 10-70% quartz stockworks and veins with 1-5% fine pyrite plus pyrrhotite plus arsenopyrite plus stibnite in sericite altered sediments. The Jubilee mineralization consists of 2%-5% disseminated pyrite, sphalerite, galena, arsenopyrite, chalcopyrite, and pyrrhotite in sediments with white to smoky grey quartz veining. Locally there is up to 10% sphalerite and semi-massive galena veinlets. The 2.5 km trend that hosts the GMZ, Richard and Jubilee Zones contains a mineralized mafic intrusive locally – similar to the South Zone, which currently hosts most of the property's last reported gold resources (September 2017). A more complete description of Clarence Stream's geology and mineralization can be found at www.galwaymetalsinc.com.

Review by Qualified Person, Quality Control and Reports

Michael Sutton, P.Geo., Director and VP of Exploration for Galway Metals, is the Qualified Person who supervised the preparation of the scientific and technical disclosure in this news release on behalf of Galway Metals Inc. All core, chip/boulder samples, and soil samples are assayed by Activation Laboratories, 41 Bittern Street, Ancaster, Ontario, Canada, who have ISO/IEC 17025 accreditation. All core is under watch from the drill site to the core processing facility. All samples are assayed for gold by Fire Assay, with gravimetric finish, and other elements assayed using ICP. The Company's QA/QC program includes the regular insertion of blanks and standards into the sample shipments, as well as instructions for duplication. Standards, blanks and duplicates are inserted at one per 20 samples. Approximately five percent (5%) of the pulps and rejects are sent for check assaying at a second lab with the results averaged and intersections updated when received. Core recovery in the mineralized zones has averaged 99%.

Table 2: Drill Hole Coordinates

Hole ID

Azimuth

Dip

Northing

Easting

Total Depth (m)

GEORGE MURPHY ZONE

GWM18CL-37

100

-60

5022449

654240

249

GWM18CL-38

139

-74

5022449

654240

411

GWM18CL-42

162

-54

5022588

654274

399

GWM18CL-39

350

-54

5022286

654289

225

GWM18CL-41

140

-45

5022440

654313

99

GWM18CL-44A

140

-45

5022397

654247

147

GWM18CL-43

142

-50

5022588

654274

392

GWM18CL-40

122

-48

5022582

654391

183

GWM18CL-58

315

-47

5022436

654342

333

GWM20BL-88

70

-45

5022033

653841

510

For results of all holes that Galway has drilled at Clarence Stream, go to Galway's website at www.galwaymetalsinc.com.

Figure 1: Plan Map of the George Murphy, Richard and Jubilee Zones

Figure 2: Plan Map of the George Murphy Zone

Figure 3: Southern Vein GMZ Longitudinal Section

Figure 4: George Murphy Longitudinal Section

About the Company

Galway Metals is well capitalized with two gold projects in Canada, Clarence Stream, an emerging gold district in New Brunswick, and Estrades, the former producing, high-grade VMS mine in Quebec. The Company began trading on January 4, 2013, after the successful spinout to existing shareholders from Galway Resources following the completion of the US$340 million sale of that company. With substantially the same management team and Board of Directors, Galway Metals is keenly intent on creating similar value as it had with Galway Resources.

Should you have any questions and for further information, please contact (toll free):

Galway Metals Inc.
Robert Hinchcliffe
President & Chief Executive Officer
1-800-771-0680
www.galwaymetalsinc.com

CAUTIONARY STATEMENT: Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy of this news release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

This news release contains forward-looking information which is not comprised of historical facts. Forward-looking information involves risks, uncertainties and other factors that could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Forward-looking information in this news release includes statements made herein with respect to, among other things, the Company's objectives, goals or future plans, potential corporate and/or property acquisitions, exploration results, potential mineralization, exploration and mine development plans, timing of the commencement of operations, and estimates of market conditions. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, exploration results being less favourable than anticipated, capital and operating costs varying significantly from estimates, delays in obtaining or failures to obtain required governmental, environmental or other project approvals, political risks, uncertainties relating to the availability and costs of financing needed in the future, changes in equity markets, inflation, changes in exchange rates, fluctuations in commodity prices, delays in the development of projects, risks associated with the defence of legal proceedings and other risks involved in the mineral exploration and development industry, as well as those risks set out in the Company's public disclosure documents filed on SEDAR. Although the Company believes that management's assumptions used to develop the forward-looking information in this news release are reasonable, including that, among other things, the Company will be able to identify and execute on opportunities to acquire mineral properties, exploration results will be consistent with management's expectations, financing will be available to the Company on favourable terms when required, commodity prices and foreign exchange rates will remain relatively stable, and the Company will be successful in the outcome of legal proceedings, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information contained herein, whether as a result of new information, future events or otherwise, except as required by applicable securities laws.

SOURCE: Galway Metals Inc.

ReleaseID: 587409

DIDCOT, UK / ACCESSWIRE / April 29, 2020 / Altus Strategies Plc (AIM:ALS & TSX-V:ALTS), the Africa focused project and royalty generator, announces that it has published its Management Discussion and Analysis for the quarter and year ended 31 December 2019. This document has been published on the Company's website at http://altus-strategies.com/investors/financials/ and on SEDAR at www.sedar.com.

For further information you are invited to visit the Company's website www.altus-strategies.com or contact:

Altus Strategies Plc

Steven Poulton, Chief Executive

Tel: +44 (0) 1235 511 767

E: info@altus-strategies.com

SP Angel (Nominated Adviser)

Richard Morrison / Soltan Tagiev

Tel: +44 (0) 20 3470 0470

SP Angel (Broker)

Abigail Wayne / Richard Parlons

Tel: +44 (0) 20 3470 0471

Blytheweigh (Financial PR)

Tim Blythe / Camilla Horsfall

Tel: +44 (0) 20 7138 3204

About Altus Strategies Plc

Altus is a London (AIM: ALS) and Toronto (TSX-V: ALTS) listed project and royalty generator in the mining sector with a focus on Africa. Our team creates value by making mineral discoveries across multiple licences. We enter joint ventures with respected groups and our partners earn interest in these discoveries by advancing them toward production. Project milestone payments we receive are reinvested to extend our portfolio, accelerating our growth. The portfolio model reduces risk as our interests are diversified by commodity and by country. The royalties generated from our portfolio of projects are designed to yield sustainable long-term income. We engage constructively with all our stakeholders, working diligently to minimise our environmental impact and to promote positive economic and social outcomes in the communities where we operate.

Cautionary Note Regarding Forward-Looking Statements

Certain information included in this Announcement, including information relating to future financial or operating performance and other statements that express the expectations of the Directors or estimates of future performance constitute "forward-looking statements". These statements address future events and conditions and, as such, involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the statements. Such factors include without limitation the completion of planned expenditures, the ability to complete exploration programmes on schedule and the success of exploration programmes. Readers are cautioned not to place undue reliance on the forward-looking information, which speak only as of the date of this Announcement and the forward-looking statements contained in this announcement are expressly qualified in their entirety by this cautionary statement.

Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. The forward-looking statements contained in this Announcement are made as at the date hereof and the Company assumes no obligation to publicly update or revise any forward-looking information or any forward-looking statements contained in any other announcements whether as a result of new information, future events or otherwise, except as required under applicable law or regulations.

TSX Venture Exchange Disclaimer

Neither the TSX Venture Exchange nor the Investment Industry Regulatory Organization of Canada accepts responsibility for the adequacy or accuracy of this release.

Market Abuse Regulation Disclosure

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 ("MAR") until the release of this announcement.

**END**

SOURCE: Altus Strategies PLC

ReleaseID: 587543

LANGLEY, BC / ACCESSWIRE / April 29, 2020 – Adastra Labs Holdings Ltd. (CSE: XTRX)(FRANKFURT: D2EP) ("Adastra" or the "Company") announces the appointment of Kyle J. Boniface as Director of Production. Dr. Boniface joins Adastra with recent publicly traded cannabis company experience as Director of Product Development and Innovation where he was responsible for cannabis extraction, product development and R&D. Dr. Boniface developed and launched a variety of cannabis products across various formats including sprays, oils, softgels, vaporizing pens and edibles. Dr. Boniface was responsible for collaborating with vendors across regional and international supply chains as well as process improvements and operational efficiency analysis.

"We are extremely excited to welcome Kyle to the Adastra team. He has exactly the experience, training, and education we need in a Director of Production. With his recent product development experience and prior role as Lead Scientist for Extraction, both with a publicly-traded Canadian cannabis company, he is the ideal choice for this role. Further, his academic credentials make him invaluable to not only the Adastra team but also to Chemia Analytics Inc. where his experience in laboratory operations will be leveraged," stated Andy Hale CEO.

Dr. Boniface holds a PhD in Chemistry from Queen's University.

About Adastra Labs Holdings Ltd.

Adastra Labs Holdings Ltd. is a Langley, BC-based cannabis company and through its wholly owned subsidiaries, Adastra Labs Inc. and Chemia Analytics Inc., is a licensed Standard Processor and licensed Analytical Testing Laboratory under the Cannabis Act administered by Health Canada, with licenses to produce cannabis extracts and provide third party analytical testing services. These licenses enable the Company's subsidiaries to produce, package, sell (wholesale), and export medically focused and recreational cannabis extract and concentrate products in Canada to other licensed entities and internationally in jurisdictions where medical cannabis extraction products are legal.

www.adastralabs.ca

Andrew Hale
Chief Executive Officer
Adastra Labs Holdings Ltd.
Phone: (778) 715-5011
Email: andy@adastralabs.ca

Stephen Brohman
Chief Financial Officer
Adastra Labs Holdings Ltd.
Phone: (778) 715-5011
Email: steve@adastralabs.ca

Address: 5451 275th Street, Langley, BC V4W 3X8
Telephone: 778-715-5011
Fax: 844-874-9893

CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION: This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate, among other things, to: Adastra's expectations concerning an fulfilling its reporting obligations. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political and social uncertainties, disruptions due to the pandemic, failures by management or service providers to complete the necessary work to meet the extended deadline. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, Adastra assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

SOURCE: Adastra Labs Holdings Ltd.

ReleaseID: 587535

MONTREAL, QC / ACCESSWIRE / April 29, 2020 / Quebec Precious Metals Corporation ("QPM" or the "Company") (TSXV:CJC)(OTCQB:CJCFF)(FSE:YXEP) has released an updated corporate presentation on the Company website. This document can be downloaded using the following link:

https://www.qpmcorp.ca/corporate-presentation/

The document includes the recent drill results on the La Pointe Extension discovery and La Pointe deposit for the Sakami project as well as on the Elmer East project (see press releases of April 21, 2020 and January 30, 2020). The ALS analytical laboratory in Val d'Or has resumed operations and the pending assays results are expected during the month of May. The Company is in the process of preparing sections and continues to update the 3D model for the Sakami project with SGS Canada Inc., which will be released using the modelling software of VRIFY Technology Inc. This will improve the understanding of the mineralization and assist in the design of future drilling programs. The 3D model on the Company's website will be updated once this work is completed.

The presentation also provides a summary in appendix of its non-core assets that are available for acquisition.

Qualified Persons

Normand Champigny, Eng., Chief Executive Officer of the Company, and Jean-Sébastien Lavallée (OGQ #773), geologist, Vice-President Exploration, director and shareholder of the Company, both Qualified Persons under NI 43- 101 on standards of disclosure for mineral projects, have prepared and approved the technical content of this release.

About Quebec Precious Metals Corporation

QPM is a gold explorer with a large land position in the highly-prospective Eeyou Istchee James Bay territory, Quebec, near Newmont Corporation's Éléonore gold mine. QPM's flagship project is the Sakami project with significant grades and well-defined drill-ready targets. QPM's goal is to find the next gold mine in this territory.

For more information please contact:

Jean-François Meilleur
President
Tel.: 514 951-2730
jfmeilleur@qpmcorp.ca

Normand Champigny
Chief Executive Officer
Tel.: 514 979-4746
nchampigny@qpmcorp.ca

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Quebec Precious Metals Corporation

ReleaseID: 587432

NEW YORK, NY / ACCESSWIRE / April 29, 2020 / HSBC (contact: 'synd manager'; telephone: +44 207 992 8066) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities

The securities:

Issuer:

PepsiCo, Inc.

Guarantor (if any):

na

Aggregate nominal amount:

EUR Benchmark / EUR Benchmark

Description:

Fixed due May 2024 / Fixed due May 2028

Offer price:

TBC / TBC

Other offer terms:

Stabilisation:

Stabilising Manager(s):

BNP Paribas, Deutsche, HSBC

Stabilisation period expected to start on:

29th April 2020

Stabilisation period expected to end no later than:

5th June 2020

Existence, maximum size & conditions of use of over-allotment facility[1]:

5% of the aggregate nominal amount

Stabilisation Venue(s)

Over the counter (OTC)

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC, as amended (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

[1] Please note that the existence and the maximum size of any greenshoe option, the exercise period of the greenshoe option and any conditions for exercise of the greenshoe option must also be disclosed, if such option exists. In addition, the exercise of the greenshoe option must be disclosed to the public promptly, together with all appropriate details, including in particular the date of exercise and the number and nature of securities involved

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: PepsiCo, Inc

ReleaseID: 587548

NEW YORK, NY / ACCESSWIRE / April 29, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

XP Shareholders Click Here: https://www.zlk.com/pslra-1/xp-inc-loss-form?prid=6243&wire=1
I Shareholders Click Here: https://www.zlk.com/pslra-1/intelsat-s-a-loss-form?prid=6243&wire=1
BIDU Shareholders Click Here: https://www.zlk.com/pslra-1/baidu-inc-information-request-form?prid=6243&wire=1

* ADDITIONAL INFORMATION BELOW *

XP Inc. (NASDAQ:XP)

XP Lawsuit on behalf of: investors who purchased or otherwise acquired XP's securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with XP's December 2019 initial public offering.
Lead Plaintiff Deadline : May 20, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/xp-inc-loss-form?prid=6243&wire=1

According to the filed complaint, (1) XP engaged in undisclosed related party transactions; (2) XP failed to disclose its common and large system failures and connected losses; (3) XP's aggressive IFA strategy was and is tenuous; (4) XP had material weaknesses; (5) XP fired its previous accounting firm due to that firm finding and disclosing material weaknesses; and (6) as a result, Defendants' public statements were materially false and misleading at all relevant times.

Intelsat S.A. (NYSE:I)

I Lawsuit on behalf of: investors who purchased November 5, 2019 – November 18, 2019
Lead Plaintiff Deadline : June 8, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/intelsat-s-a-loss-form?prid=6243&wire=1

The complaint filed against BC Partners, its individual partners and directors of Intelsat Raymond Svider and Justice Bateman, and Silver Lake Group, L.L.C. (and its related entities) alleges that throughout the class period, defendants made false and misleading statements to the market. Specifically, the complaint alleges that Silver Lake and its fellow defendants violated the Exchange Act by selling a block of Intelsat's shares while holding material non-public information, including the fact that the Company had met with the Federal Communications Commission (the "FCC") on November 5, 2019 to discussed the sale of spectrum controlled by Intelsat for future "5G" use (the "C-Band"). The FCC opposed Intelsat's proposal for a private sale of the C-Band, preferring a public auction. The FCC announced a public auction of the C-Band on November 18, 2019, contrary to Intelsat's wishes, its stock dropped 40%.

Baidu, Inc. (NASDAQ:BIDU)

BIDU Lawsuit on behalf of: investors who purchased March 16, 2019 – April 7, 2020
Lead Plaintiff Deadline : June 22, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/baidu-inc-information-request-form?prid=6243&wire=1

According to the filed complaint, during the class period, Baidu, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Baidu's feed services were not in compliance with applicable Chinese regulatory standards; (ii) the foregoing noncompliance subjected the Company to a heightened risk of regulatory enforcement, including the removal or suspension of certain of Baidu's services and products; (iii) accordingly, the Company's revenues derived from online marketing services were unlikely to be sustainable; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 587545

SHELTON, CT / ACCESSWIRE / April 29, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, today announced that the Company's presentation with an update of its drug development programs for the treatment of Shingles and for COVID-19 made at the Planet MicroCap Showcase 2020 on April 22nd is now available for viewing. Anil R. Diwan, PhD, President and Executive Chairman of the Company, presented this Corporate Update.

The archived presentation is now available for on-demand playback by accessing the following link: https://www.webcaster4.com/Webcast/Page/2059/34392

The archived presentation has the full audio track linked to the slides. There was a technical error whereby the slides were not changing during the live presentation. Therefore, the Company encourages people to visit the archived presentation.

Key takeaways from the presentation are as follows.

COVID-19 Update:

The Company has drug candidates that were highly successful in cell culture studies against multiple coronaviruses.
The observed broad-spectrum anti-coronavirus activity of these drug candidates provides confidence that even as the virus mutates, the selected nanoviricide drug would continue to be effective against it.
The Company's technology goes well beyond antibodies in attacking the virus particle. Whereas an antibody binds to the virus only at two points, a nanoviricide is designed to bind to the virus at several points, like a nano-scale "Velcro" tape, and further to encapsulate the virus, thereby disabling it from infecting a cell.
Viruses can escape antibodies due to genomic changes including mutations. However, a virus continues to bind to the same cellular receptor with the same "footprint". A nanoviricide is designed by attempting to mimic this footprint, and therefore, it is expected that it would continue to be effective in spite of changes in the virus.
A nanoviricide is designed to act like a "Venus-fly-Trap" for viruses.
The Company is anticipating a collaboration to enable testing against SARS-CoV-2, the virus that causes the COVID-19 disease.
The Company has worked on developing an animal model to test anti-coronavirus effectiveness in vivo using a model coronavirus that binds to the same ACE2 ("angiotensin convertase enzyme 2") receptor as SARS-CoV-2, namely human coronavirus NL-63 (hCoV-NL63). The Company anticipates using this animal model to obtain indications of effectiveness of the nanoviricide test drug candidates against the model coronavirus in vivo.

Shingles Candidate IND Update:

The Company's first IND application for the use of NV-HHV-101 Skin Cream for Shingles Rash treatment is being prepared by us and is being reviewed by the Company's regulatory consultants.
The Company is currently working on establishing collaborations with clinical regulatory consultants and is evaluating clinical site selections.
The Company has developed a preliminary clinical plan and is preparing the more detailed clinical plan to be included in the IND application.

The Company is developing broad-spectrum drugs against coronaviruses by developing mimics of the ACE2 receptor to which SARS-CoV-2, SARS-CoV-1, hCoV-NL-63 and possibly some other coronaviruses bind. The Company has previously developed a broad-spectrum anti-herpesvirus drug candidate. This candidate, originally developed to be active against HSV-1, the virus that causes cold sores, was found to be effective against HSV-2, the virus that causes genital ulcers, and also against VZV, the virus that causes chickenpox and shingles. Of these, HSV-1 and HSV-2 are known to bind to the HVEM ("herpesvirus entry mediator") cellular receptor, which the Company mimicked to produce the drug candidates against herpesviruses. It is not definitively known whether VZV binds to HVEM. NV-HHV-101 is the Company's lead drug candidate that has completed IND-enabling studies, and is ready for human clinical trials, once the IND process is completed.

NanoViricides is one of a few biopharma companies that has its own cGMP-compliant manufacturing facility. The Company intends to produce its drugs for clinical trials in this facility. The Company has the capability to produce sufficient drug for about 1,000 patients in a single batch of production, depending upon dosage. This production capacity is anticipated to be sufficient for first-in-human use in the current SARS-CoV-2 pandemic, as well as for the anticipated clinical trials of NV-HHV-101.

About NanoViricides, Inc.

NanoViricides, Inc. (www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for antiviral therapy. Our lead drug candidate is NV-HHV-101 with its first indication as dermal topical cream for the treatment of shingles rash. The Company is also developing drugs against SARS-CoV-2 virus for the treatment of COVID-19 disease, and a number of other viral diseases including oral and genital Herpes, viral diseases of the eye including EKC and herpes keratitis, H1N1 swine flu, H5N1 bird flu, seasonal Influenza, HIV, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others. The Company's novel nanoviricide® class of drug candidates are designed to specifically attack virus particles by mimicking the same receptor sites that viruses use to bind to cells, enveloping and then dismantling them, thereby blocking the reinfection cycle. This goes beyond what antibodies and immunotherapeutics can do. Our unique biomimetic approach enables creation of drugs that a virus would be highly unlikely to escape due to mutations. The Company's technology is based on broad, exclusive, sub-licensable, field licenses from TheraCour Pharma, Inc. While the Company does not currently have a license to the coronavirus field, TheraCour has not denied any licenses to the Company. The Company typically begins the licensing process only after demonstrating effectiveness of some candidates in optimization stage.

Safe Harbor Statement

This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by NanoViricides, Inc. are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company's expectations include, but are not limited to, those factors that are disclosed under the heading "Risk Factors" and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities. Although it is not possible to predict or identify all such factors, they may include the following: demonstration and proof of principle in preclinical trials that a nanoviricide is safe and effective; successful development of our product candidates; our ability to seek and obtain regulatory approvals, including with respect to the indications we are seeking; the successful commercialization of our product candidates; and market acceptance of our products.

As with any drug development efforts, there can be no assurance that any of these candidates would show sufficient effectiveness and safety for human clinical development at this time. There can be no assurance that the Company will be successful in establishing the necessary collaborations, although the Company has been successful at establishing necessary collaborations for its drug programs in the past.

About Planet MicroCap Showcase

Planet MicroCap Showcase brings together promising companies with well-known and influential microcap, investors, fund managers and newsletter writers for three days of company presentations, one-on-one meetings, and networking.

After the event, all company presentations "webcasts" will be available directly on the conference event platform on this link under the tab "Schedule": https://www.planetmicrocapshowcase.com/presenting-companies.

Contact:

NanoViricides, Inc.

info@nanoviricides.com

Public Relations Contact:

MJ Clyburn, TraDigital IR

clyburn@tradigitalir.com

——————————————————————————–

SOURCE: NanoViricides, Inc.

ReleaseID: 587537

Further Metallurgical Test Work Continues to Add Improvements and Modelled Revenue Increases at Alpala

BISHOPSGATE, LONDON / ACCESSWIRE / April 29, 2020 / The Board of Directors of SolGold (LSE:SOLG)(TSX:SOLG) is pleased to provide an update on the ongoing comprehensive metallurgical test work programme underway at the Company's flagship Alpala copper-gold porphyry Project in northern Ecuador.

Following the completion of further metallurgical test work at Alpala, the Company has received the Phase 2 Test Work Report by ALS Metallurgical Laboratories, Canada. Phase 1 and 2 together represent an evaluation of the metallurgy for the whole planned mine life of the Alpala deposit.

Improved recoveries in metallurgical tests across all valuable minerals indicate a potential increase in the revenues from the Alpala project. Results from these metallurgical test programmes form important elements of the Pre-Feasibility Study ("PFS") currently underway. Phase 2 allowed SolGold to conduct flowsheet optimisation testing followed by flowsheet development.

Highlights of the Phase 2 metallurgical test-work:

·Life of mine increase in gold recovery by 7% compared to results of the Preliminary Economic Assessment ("PEA") filed on 19 November 2019

·Ability to produce 26%-30% copper concentrate (plus gold and silver) for modelled life of mine

·Low deleterious elements in concentrate for life of mine, such as arsenic, bismuth, cadmium, fluorine and others (see glossary)

·All composite samples from Phase 2 (as in Phase 1) responded well to conventional froth floatation with high valuable metal recovery rates overall

·Mineralogical testing confirmed that the copper sulphide mineral was substantially chalcopyrite

The Phase 2 test work programme following the PEA, builds on initial previously reported Phase 1 test work (PEA) and includes:

·Confirmatory tests on samples representative of the initial ten years of the mine life

·Expansion of tests with a focus on years ten to twenty of the mine life

·Tests to evaluate performance on lower grade material in the later mine life (after year 20)

The Phase 2 test work programme was based upon further composite samples from 785 metres (1,437kg) of core from previous diamond drilling at the Alpala project. This generated a total of 33 variability composites (each comprising 24 metres of core) as well as four master composites. The master composites represent low, medium (x2) and high grade feed material. To date, a total of 1,265 metres (2,417kgs) of core has been analysed and metallurgically assessed as part of both Phase 1 and Phase 2 of the metallurgical programme, comprising 53 variability samples and seven master composites.

Table 1 below shows the full spectrum of project feed grades covered in both Phase 1 and Phase 2.

Please click on the PDF to view the full announcement:
http://www.rns-pdf.londonstockexchange.com/rns/2405L_1-2020-4-28.pdf

Figure 1: Composite feed grades for Phase 1 (PH1) and Phase 2 (PII) test programmes.

Mine Years

Composite

Feed Grade

Cu

%

Ag

g/t

Au

g/t

Phase 1 Report

(Years 1-10)

PH1-HG

2.02

4.2

3.12

PH1-IG

1.18

2.2

2.61

PH1-LG

0.79

1.6

0.47

Phase 2 Report

(Years 1-49)

PII-LG

0.21

1.0

0.12

PII-MG1

0.42

1.0

0.18

PII-MG2

0.63

1.5

0.36

PII-HG

1.53

5.5

1.13

Note: indicated sample position in the 50Mt/a fast ramp up case as per PEA

Figure 2: Graph showing metallurgical samples over modelled mine life

Commenting on the results, Nicholas Mather, SolGold's Chief Executive Officer commented:

"Despite current disruptions due to COVID-19, the SolGold team continues to progress large scale metallurgical test work at Alpala. The results of this are being used to assess potential refinements to the flowsheet and our operating and capital cost estimates as well as improvements in revenues generated by upgraded recoveries. In addition, these results continue to demonstrate the high-quality of Alpala concentrate and form an important part of our current offtake negotiations with leading traders and smelters."

Greg Harbort, General Manager of Process and Metallurgy said:

"The comprehensive test programme completed thus far has once again produced encouraging results. The flotation tests have demonstrated the ability to produce a high grade dominantly chalcopyrite concentrate throughout the modelled mine life and confirms the Alpala project to be a very low deleterious content deposit. Variability test work conducted so far has shown that production can occur effectively at any point on the grade-recovery curve, positioning the modelled mine robustly in terms of possible concentrate market changes."

Background to Phase 2 Metallurgical Test Work

In Phase 2, efforts were focused on optimising the process flowsheet using the test results of the four master composites, prepared from the 33 variability samples. The developed flowsheet was then applied to the 33 individual variability samples. Locked cycle tests were initially run with water sourced from site, and no water recycle. Locked cycle tests have for several decades, been the industry standard method used to simulate plant operation (with regard to recirculating loads, water quality and reagent usage) and optimal metallurgical recovery circuit design.

The tests were then repeated with recycled water to simulate process water use on site. This produced eight sets of locked cycle results, with feed grades varying from 0.21% Cu to 1.53% Cu. Recovered copper concentrate grades ranged from 25.7% to 30.1% copper content. Gold in the concentrate varied from 10.3 g/t to 16.7 g/t, and silver from 45 g/t to 93 g/t. Extended analysis showed very low deleterious elements in the concentrate (Figure 6), well below any applicable penalty limits.

SolGold considers that following suitable regrind and cleaning stages, it may be possible to produce a saleable magnetite concentrate. Tailings from each of the rougher flotation variability tests were subjected to Davis Tube Recovery tests to evaluate the potential for magnetite recovery. The tests were conducted at the 'as received' grind size (typically 150 µm) at a magnetic intensity of 4,000 Gauss. Magnetite recoveries were calculated based on the flotation feed mineralogy. The results indicate that at a feed grade of greater than 2.5% magnetite, a concentrate grading >40% magnetite can be produced. Magnetite recoveries (to concentrate) averaged 85%. SolGold is continuing to evaluate by-product magnetite recovery.

Figure 3: Composite recoveries and concentrate grades (based on test work mass balance) for Phase 1 and Phase 2 test programmes.

Phase

Sample

Recovery

Concentrate Grade

Cu

%

Au

%

Ag

%

Cu

%

Au

g/t

Ag

g/t

1

Low Copper Master Composite

86.0

78.7

56.3

30.4

28.3

45.0

1

Intermediate Copper Master Composite

92.5

81.2

74.2

28.4

46.2

39.0

1

High Copper Master Composite

93.1

85.8

78.8

30.7

41.0

58.0

2

(Fresh site water)

Low Grade Master Composite

78.2

50.1

26.8

28.5

10.3

48.0

Medium Grade Master Composite No 1

83.3

68.7

62.3

29.5

10.4

52.0

Medium Grade Master Composite No 2

87.7

63.6

62.4

27.2

10.7

46.0

High Grade Master Composite

94.9

70.0

56.4

29.7

16.1

93.0

2

(Fresh water/ no water recycle)

Low Grade Master Composite

81.8

46.5

19.3

27.9

10.5

47.0

Medium Grade Master Composite No 1

83.3

67.1

26.6

28.0

10.8

53.0

Medium Grade Master Composite No 2

86.0

65.7

60.5

25.7

10.9

45.0

High Grade Master Composite

94.8

75.9

79.3

30.1

16.7

91.0

Flotation Recovery

A substantial focus of SolGold's Phase 2 test work centred on adjustments to the flotation circuit design and reagent regime in order to increase gold recovery.

Phase 2 locked cycle testing of the Alpala ores indicates a 7% increase in life of mine gold recovery compared to the PEA. As indicated in Figure 4, substantial improvements in recovery are expected to be achieved from year twenty onwards.

Predicted copper recoveries were consistent with the Phase 1 (PEA) predictions for years 1 to 10, but approximately 1% lower over years 10-30. Overall this represents a 0.51% decrease in copper recovery compared to modelled recoveries referred to in the PEA.

Tailings from the cleaner cells were collected into ten composites and subjected to bottle roll cyanidation test work to evaluate the extraction of copper, gold and silver in an effort to further enhance recoveries of these metals.

An additional two composites were used to evaluate recoveries from biological and thiosulphate leaching. The grade of the cyanidation composites varied from 0.29 g/t Au to 2.68 g/t Au, with gold extraction from the cleaner tailing, based on a 72-hour residence time, varying from 46% to 88% from cleaner cell tailings.

Leach enhancement via an acid wash increased gold extraction to between 58% and 89% from the cleaner cell tailings. Twenty-one days biological oxidation followed by cyanidation increased the gold extraction to 93%. Cyanide consumption ranged between 0.8 kg/t and 6.2 kg/t.

Figure 4: Flotation gold recovery showing improved benefit in the mid-late life period of the mine.

Figure 5: Flotation copper recovery consistent with predicted performance to PEA.

Figure 6: Extended Analysis – Locked Cycle Test Copper Concentrate Quality (Phase 2 Report)

Element

Symbol

Units

Sample

LG

MG1

MG2

HG

T54 Cycle V+VI Copper Con

T50/55 V+VI Copper Con

T52/56 V+VI Copper Con

T53/57 V+VI Copper Con

Antimony

Sb

g/tonne

7.1

2.4

4

15

Arsenic

As

g/tonne

18

21

92

70.5

Bismuth

Bi

g/tonne

5.3

6.3

8.0

9.4

Cadmium

Cd

g/tonne

12.6

4.6

9.1

16.3

Chlorine

Cl

g/tonne

<50

<50

<50

<50

Copper*

Cu

%

27.9

28.8

26.4

29.9

Fluorine

F

g/tonne

60

55

60

<20

Gold*

Au

g/tonne

10.3

10.6

10.8

16.4

Iron*

Fe

%

28.0

28.9

30.7

30.5

Lead

Pb

g/tonne

533

83

88

148

Magnesium

Mg

%

0.30

0.18

0.21

0.05

Mercury

Hg

g/tonne

<1

<1

<1

<1

Organic Carbon

TOC

%

0.11

0.08

0.06

0.04

Selenium

Se

g/tonne

110

135

140

180

Silver*

Ag

g/tonne

47

53

46

92

Sulphur(S)*

S

%

32.8

33.9

35.4

36.0

Tellurium

Te

g/tonne

7.8

5.35

7.9

10.1

Zinc

Zn

g/tonne

1260

260

785

2420

Source: ALS Phase 2 Report 2020
Notes: a) *Cu, Fe, Au, Ag and S assays were taken from locked cycle test assays completed at ALS Metallurgy Kamloops, Canada; results for other metals were sourced from assays completed at ALS Geochemistry in North Vancouver, Canada.
b) Values indicate averages of determinations completed on individual concentrates from each locked-cycle test.
c) Complete multi-element ICP analyses along with other external concentrate assays can be located in Appendix V – Special Data in the full ALS Phase 2 Report
d) Details of extended analysis as included in the full ALS Phase 2 Report

Further Planned Test Work

As part of the PFS (and ultimate DFS), SolGold continues to advance its metallurgical test work programme. This includes plans for a bulk sampling programme to generate 20 to 30 tonnes of material for pilot plant evaluation. This will include vendor thickening and filtration tests, transportable moisture limits (TML) for shipment, rheology tests for concentrate and tailing pipelines and further tailing characterisation work. In addition, selected sample will be used for crushing tests and pyrite concentrate will be produced for further leach evaluation. If warranted, tailings will be evaluated for more detailed magnetite recovery. The Company will provide a further update on this in due course.

SolGold's on site operations in Ecuador are currently halted in an effort to reduce the potential transmission of COVID-19. SolGold continues to actively monitor all its employees. Health and safety are top priorities for the Company and SolGold will continue supporting its employees and local communities where possible in their efforts to curtail the spread of the virus.

By order of the Board
Karl Schlobohm
Company Secretary

Glossary

Chalcopyrite: CuFeS2 and the main copper ore mineral accounting for approximately half of all copper production

Cleaner: final section of flotation recovery circuit, focussing on increasing concentrate grades

Comminution: section of the mineral processing circuit that reduces the size of the ore fragments to a suitable size for flotation

Deleterious elements: elements that reduce product saleability such as arsenic, bismuth, cadmium, chlorine, fluorine, mercury, selenium, tellurium and uranium

Locked cycle: a repetitive batch used to simulate a continuous metal recovery circuit

Rougher: initial section of a flotation recovery circuit, focusing on maximising metal recovery at variable concentrate grades.

Qualified Person:

Information in this report relating to the exploration results is based on data reviewed by Mr Jason Ward ((CP) B.Sc. Geol.), the Chief Geologist of the Company. Mr Ward is a Fellow of the Australasian Institute of Mining and Metallurgy, holds the designation FAusIMM (CP), and has in excess of 20 years' experience in mineral exploration and is a Qualified Person for the purposes of the relevant LSE and TSX Rules. Mr Ward consents to the inclusion of the information in the form and context in which it appears.

Market Abuse Regulation (MAR) Disclosure

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of the Regulation (EU) No 596/2014 until the release of this announcement.

CONTACTS

Nicholas Mather

SolGold Plc (Chief Executive Officer) nmather@solgold.com.au

Tel: +61 (0) 7 3303 0665

+61 (0) 417 880 448

Karl Schlobohm

SolGold Plc (Company Secretary)

kschlobohm@solgold.com.au

Tel: +61 (0) 7 3303 0661

Ingo Hofmaier

SolGold Plc (GM – Project & Corporate Finance) ihofmaier@solgold.com.au

Tel: +44 (0) 20 3823 2131

Gordon Poole / Nick Hennis

Camarco (Financial PR / IR)

solgold@camarco.co.uk

Tel: +44 (0) 20 3757 4997

Ross Allister / David McKeown

Peel Hunt (Joint Broker and Financial Advisor)

solgold@peelhunt.com

Tel: +44 (0)20 7418 8900

James Kofman / Darren Wallace

Cormark Securities Inc. (Financial Advisor)

dwallace@cormark.com

Tel: +1 416 943 6411

Follow us on twitter @SolGold_plc

ABOUT SOLGOLD

SolGold is a leading resources company focussed on the discovery, definition and development of world-class copper and gold deposits. In 2018, SolGold's management team was recognised by the "Mines and Money" Forum as an example of excellence in the industry and continues to strive to deliver objectives efficiently and in the interests of shareholders. SolGold is the largest and most active concession holder in Ecuador and is aggressively exploring the length and breadth of this highly prospective and gold-rich section of the Andean Copper Belt.

The Company operates with transparency and in accordance with international best practices. SolGold is committed to delivering value to its shareholders, while simultaneously providing economic and social benefits to impacted communities, fostering a healthy and safe workplace and minimizing the environmental impact.

Dedicated stakeholders

SolGold employs a staff of 737 employees of whom 98% are Ecuadorean. This is expected to grow as the operations expand at Alpala, and in Ecuador generally. SolGold focusses its operations to be safe, reliable and environmentally responsible and maintains close relationships with its local communities. SolGold has engaged an increasingly skilled, refined and experienced team of geoscientists using state of the art geophysical and geochemical modelling applied to an extensive database to enable the delivery of ore grade intersections from nearly every drill hole at Alpala. SolGold has 86 geologists, of whom 30% are female, on the ground in Ecuador exploring for economic copper and gold deposits.

About Cascabel and Alpala

The Alpala deposit is the main target in the Cascabel concession, located on the northern section of the heavily endowed Andean Copper Belt, the entirety of which is renowned as the base for nearly half of the world's copper production. The project area hosts mineralisation of Eocene age, the same age as numerous Tier 1 deposits along the Andean Copper Belt in Chile and Peru to the south. The project base is located at Rocafuerte within the Cascabel concession in northern Ecuador, an approximately three-hour drive on sealed highway north of the capital Quito, close to water, power supply and Pacific ports.

Having fulfilled its earn-in requirements, SolGold is a registered shareholder with an unencumbered legal and beneficial 85% interest in ENSA (Exploraciones Novomining S.A.) which holds 100% of the Cascabel concession covering approximately 50km2. The junior equity owner in ENSA is required to repay 15% of costs since SolGold's earn in was completed, from 90% of its share of distribution of earnings or dividends from ENSA or the Cascabel concession. It is also required to contribute to development or be diluted, and if its interest falls below 10%, it shall reduce to a 0.5% NSR royalty which SolGold may acquire for US$3.5m.

Advancing Alpala towards development

The resource at the Alpala deposit boasts a high-grade core which is targeted to facilitate early cashflows and an accelerated payback of initial capital. SolGold is currently assessing financing options available to the Company for the development of the Alpala mine following completion of the Definitive Feasibility Study.

Mineral Resource Estimate #3:

·Mineral Resource of 2,663 Mt @ 0.53% CuEq for 9.9 Mt Cu, 21.7 Moz Au and 92.2 Moz Ag in the Measured plus Indicated categories.

·Mineral Resource of 544 Mt @ 0.31% CuEq for 1.3 Mt Cu, 1.9 Moz Au and 10.6 Moz Ag in the Inferred category

SolGold's Regional Exploration Drive

SolGold is using its successful and cost-efficient blueprint established at Alpala, and Cascabel generally, to explore for additional world class copper and gold projects across Ecuador. SolGold is the largest and most active concessionaire in Ecuador.

The Company wholly owns four other subsidiaries active throughout the country that are now focussed on thirteen high priority gold and copper resource targets, several of which the Company believes have the potential, subject to resource definition and feasibility, to be developed in close succession or even on a more accelerated basis compared to Alpala.

SolGold is listed on the London Stock Exchange and Toronto Stock Exchange (LSE/TSX: SOLG). The Company has on issue a total of 1,923,321,033 fully-paid ordinary shares and 185,162,000 unlisted options exercisable at various prices ranging from 25p to 60p and expiring between July 2020 and November 2024.

Quality Assurance / Quality Control on Sample Collection, Security and Assaying

SolGold operates according to its rigorous Quality Assurance and Quality Control (QA/QC) protocol, which is consistent with industry best practices.

Primary sample collection involves secure transport from SolGold's concessions in Ecuador, to the ALS certified sample preparation facility in Quito, Ecuador. Samples are then air freighted from Quito to the ALS certified laboratory in Lima, Peru where the assaying of drill core, channel samples, rock chips and soil samples is undertaken. SolGold utilises ALS certified laboratories in Canada and Australia for the analysis of metallurgical samples.

Samples are prepared and analysed using 100g 4-Acid digest ICP with MS finish for 48 elements on a 0.25g aliquot (ME-MS61). Laboratory performance is routinely monitored using umpire assays, check batches and inter-laboratory comparisons between ALS certified laboratory in Lima and the ACME certified laboratory in Cuenca, Ecuador.

In order to monitor the ongoing quality of its analytical database, SolGold's QA/QC protocol encompasses standard sampling methodologies, including the insertion of certified powder blanks, coarse chip blanks, standards, pulp duplicates and field duplicates. The blanks and standards are Certified Reference Materials supplied by Ore Research and Exploration, Australia.

SolGold's QA/QC protocol also monitors the ongoing quality of its analytical database. The Company's protocol involves Independent data validation of the digital analytical database including search for sample overlaps, duplicate or absent samples as well as anomalous assay and survey results. These are routinely performed ahead of Mineral Resource Estimates and Feasibility Studies. No material QA/QC issues have been identified with respect to sample collection, security and assaying.

Reviews of the sample preparation, chain of custody, data security procedures and assaying methods used by SolGold confirm that they are consistent with industry best practices and all results stated in this announcement have passed SolGold's QA/QC protocol.

See www.solgold.com.au for more information. Follow us on twitter @SolGold_plc

CAUTIONARY NOTICE

News releases, presentations and public commentary made by SolGold plc (the "Company") and its Officers may contain certain statements and expressions of belief, expectation or opinion which are forward looking statements, and which relate, inter alia, to interpretations of exploration results to date and the Company's proposed strategy, plans and objectives or to the expectations or intentions of the Company's Directors. Such forward-looking and interpretative statements involve known and unknown risks, uncertainties and other important factors beyond the control of the Company that could cause the actual performance or achievements of the Company to be materially different from such interpretations and forward-looking statements.

Accordingly, the reader should not rely on any interpretations or forward-looking statements; and save as required by the exchange rules of the TSX and LSE or by applicable laws, the Company does not accept any obligation to disseminate any updates or revisions to such interpretations or forward-looking statements. The Company may reinterpret results to date as the status of its assets and projects changes with time expenditure, metals prices and other affecting circumstances.

This release may contain "forward‑looking information" within the meaning of applicable Canadian securities legislation. Forward‑looking information includes, but is not limited to, statements regarding the Company's plans for developing its properties. Generally, forward‑looking information can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved".

Forward‑looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward‑looking information, including but not limited to: transaction risks; general business, economic, competitive, political and social uncertainties; future prices of mineral prices; accidents, labour disputes and shortages and other risks of the mining industry. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward‑looking information. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.

The Company and its officers do not endorse, or reject or otherwise comment on the conclusions, interpretations or views expressed in press articles or third-party analysis, and where possible aims to circulate all available material on its website.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: SolGold plc

ReleaseID: 587510

NEW YORK, NY / ACCESSWIRE / April 29, 2020 / Halper Sadeh LLP, a global investor rights law firm, announces the filing of a shareholder class action lawsuit against Legg Mason, Inc. (NYSE:LM) in connection with the proposed sale of Legg Mason to Franklin Resources, Inc. for $50.00 per share. The lawsuit seeks damages and/or equitable relief on behalf of Legg Mason shareholders under the federal securities laws.

If you are a Legg Mason shareholder and would like to join the action or discuss your legal rights and options, please visit Legg Mason Class Action or contact Daniel Sadeh or Zachary Halper, free of charge, at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

The lawsuit alleges that Defendants issued a materially misleading proxy statement recommending that Legg Mason shareholders vote in favor of the proposed sale of Legg Mason to Franklin Resources. According to the complaint, the proxy statement contains materially incomplete and misleading information concerning, among other things, Legg Mason's financial projections and analyses performed by Legg Mason's financial advisors.

If you wish to serve as lead plaintiff, you must move the Court no later than June 22, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you would like to join the action or discuss your legal rights and options, please visit https://halpersadeh.com/actions/legg-mason-inc-merger-stock-franklin-resources/ or contact Daniel Sadeh or Zachary Halper, free of charge, at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE OR YOU MAY REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLP

Daniel Sadeh, Esq.

Zachary Halper, Esq.

(212) 763-0060

sadeh@halpersadeh.com

zhalper@halpersadeh.com

https://www.halpersadeh.com

SOURCE: Halper Sadeh LLP

ReleaseID: 587536

NEW YORK, NY / ACCESSWIRE / April 29, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders:

Taubman Centers, Inc. (NYSE: TCO)

The investigation concerns whether Taubman and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Taubman to Simon Property Group, Inc. for $52.50 per share in cash. If you are a Taubman shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/taubman-centers-inc-merger-stock-simon-property-group/.

Willis Towers Watson Public Limited Company (NASDAQ: WLTW)

The investigation concerns whether Willis Towers and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the sale of Willis Towers to Aon plc for 1.08 Aon ordinary shares for each Willis Towers ordinary share. If you are a Willis Towers shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/willis-towers-watson-public-limited-company-wltw-stock-merger-aon-plc/.

Opus Bank (NASDAQ: OPB)

The investigation concerns whether Opus Bank and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Opus Bank to Pacific Premier Bancorp, Inc. If you are an Opus Bank shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/opus-bank-opb-stock-merger-pacific-premier/.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLP

Daniel Sadeh, Esq.

Zachary Halper, Esq.

(212) 763-0060

sadeh@halpersadeh.com

zhalper@halpersadeh.com

https://www.halpersadeh.com

SOURCE: Halper Sadeh LLP    

ReleaseID: 587534